Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Operating expenses:
Research and development	$ 21,369	$ 18,323	$ 42,902	$ 37,059
General and administrative	5,714	4,491	11,006	9,636
Total operating expenses	27,083	22,814	53,908	46,695
Loss from operations	(27,083)	(22,814)	(53,908)	(46,695)
Other income (expense):
Interest income	241	998	424	2,185
Change in fair value of the tranche rights	0	0	0	(4,796)
Other income (expense), net	22	436	1,191	(1,658)
Total other income (expense)	263	1,434	1,615	(4,269)
Net loss	$ (26,820)	$ (21,380)	$ (52,293)	$ (50,964)
Net loss per share, basic (in usd per share)	$ (0.20)	$ (0.21)	$ (0.45)	$ (0.51)
Net loss per share, diluted (in usd per share)	$ (0.20)	$ (0.21)	$ (0.45)	$ (0.51)
Weighted-average common shares outstanding, basic (in shares)	132,175,202	101,272,580	116,844,985	99,607,158
Weighted-average common shares outstanding, diluted (in shares)	132,175,202	101,272,580	116,844,985	99,607,158